Estrogen Receptor Folding Modulates cSrc Kinase SH2 Interaction via a Helical Binding Mode.

No abstract is available for this paper.

• Publication year

  2015

• Venue

  ACS Chemical Biology

• Publication date

  2015-11-20

• Fields of study

  Biology, Medicine, Chemistry

• Identifiers
  DOI 10.1021/acschembio.5b00568PMID 26352092
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Subtype-specific modulation of estrogen receptor-coactivator interaction by phosphorylation.

  2015cited by this paper
• Emergence of Constitutively Active Estrogen Receptor-α Mutations in Pretreated Advanced Estrogen Receptor–Positive Breast Cancer

  2014cited by this paper
• Endocrine-therapy-resistant ESR1 variants revealed by genomic characterization of breast-cancer-derived xenografts.

  2013cited by this paper
• Activating ESR1 mutations in hormone-resistant metastatic breast cancer

  2013cited by this paper
• ESR1 ligand binding domain mutations in hormone-resistant breast cancer

  2013cited by this paper
• Activating ESR 1 mutations in hormone-resistant metastatic breast cancer

  2013cited by this paper
• ERα phosphorylation at Y537 by Src triggers E6-AP-ERα binding, ERα ubiquitylation, promoter occupancy, and target gene expression.

  2012cited by this paper
• Cracking the estrogen receptor's posttranslational code in breast tumors.

  2011cited by this paper
• Phage display selection of miniprotein binders of the Estrogen Receptor.

  2010cited by this paper
• Conformational Determinants of Phosphotyrosine Peptides Complexed with the Src SH2 Domain

  2010cited by this paper
• Estrogen Receptor Alpha Phosphorylated at Tyrosine 537 is Associated with Poor Clinical Outcome in Breast Cancer Patients Treated with Tamoxifen

  2010cited by this paper
• Synthesis and Crystal Structure of a Phosphorylated Estrogen Receptor Ligand Binding Domain

  2010cited by this paper
• Is there an association with phosphorylation and dephosphorylation of Src kinase at tyrosine 530 and breast cancer patient disease-specific survival

  2010cited by this paper
• Challenging estrogen receptor beta with phosphorylation.

  2010cited by this paper
• Systematic Mapping of Posttranslational Modifications in Human Estrogen Receptor-α with Emphasis on Novel Phosphorylation Sites*S

  2009cited by this paper
• Structure, dynamics, and binding thermodynamics of the v‐Src SH2 domain: Implications for drug design

  2008cited by this paper
• MNAR plays an important role in ERa activation of Src/MAPK and PI3K/Akt signaling pathways.

  2008cited by this paper
• Sex-steroid hormones and EGF signalling in breast and prostate cancer cells: targeting the association of Src with steroid receptors.

  2008cited by this paper
• Inhibition of Estradiol Receptor/Src Association and Cell Growth by an Estradiol Receptor α Tyrosine-Phosphorylated Peptide

  2007cited by this paper
• Estrogen receptors: how do they signal and what are their targets.

  2007cited by this paper
• Estrogen signaling multiple pathways to impact gene transcription.

  2006cited by this paper
• Post-translational modifications of steroid receptors.

  2006cited by this paper
• Structural basis for phosphotyrosine recognition by the Src homology-2 domains of the adapter proteins SH2-B and APS.

  2006cited by this paper
• Comparison of multiple Amber force fields and development of improved protein backbone parameters

  2006cited by this paper
• The Amber biomolecular simulation programs

  2005cited by this paper
• Steroid-hormone rapid actions, membrane receptors and a conformational ensemble model

  2004cited by this paper
• SH 2 Domains Recognize Specific Phosphopeptide Sequences

  2004cited by this paper
• c-Src and cooperating partners in human cancer.

  2004cited by this paper
• Characterization of the interactions of estrogen receptor and MNAR in the activation of cSrc.

  2004cited by this paper
• Nongenomic actions of steroid hormones

  2003cited by this paper
• Combinatorial Control of Gene Expression by Nuclear Receptors and Coregulators

  2002cited by this paper
• Structure, dynamics and binding characteristics of the second PDZ domain of PTP-BL.

  2002cited by this paper
• Combinatorial control of gene expression by nuclear receptors and coregulators.

  2002cited by this paper
• Steroid‐induced androgen receptor–oestradiol receptor β–Src complex triggers prostate cancer cell proliferation

  2000cited by this paper
• Role of Src expression and activation in human cancer

  2000cited by this paper
• Nuclear receptor coregulators: cellular and molecular biology.

  1999cited by this paper
• Calorimetric examination of high-affinity Src SH2 domain-tyrosyl phosphopeptide binding: dissection of the phosphopeptide sequence specificity and coupling energetics.

  1999cited by this paper
• Function of estrogen receptor tyrosine 537 in hormone binding, DNA binding, and transactivation.

  1999cited by this paper
• A unified nomenclature system for the nuclear receptor superfamily

  1999cited by this paper
• A unified nomenclature system for the nuclear receptor superfamily.

  1999cited by this paper
• Ligand-independent activation of the estrogen receptors alpha and beta by mutations of a conserved tyrosine can be abolished by antiestrogens.

  1998cited by this paper
• Different positioning of the ligand‐binding domain helix 12 and the F domain of the estrogen receptor accounts for functional differences between agonists and antagonists

  1998cited by this paper
• Ligand-independent Activation of the Estrogen Receptors α and β by Mutations of a Conserved Tyrosine Can Be Abolished by Antiestrogens

  1998cited by this paper
• Probing the "two-pronged plug two-holed socket" model for the mechanism of binding of the Src SH2 domain to phosphotyrosyl peptides: a thermodynamic study.

  1998cited by this paper
• Peptide ligands of pp60(c-src) SH2 domains: a thermodynamic and structural study.

  1997cited by this paper
• An estrogen receptor mutant with strong hormone-independent activity from a metastatic breast cancer.

  1997cited by this paper
• Molecular basis of agonism and antagonism in the oestrogen receptor

  1997cited by this paper
• Localizing the NADP+ binding site on the MurB enzyme by NMR

  1996cited by this paper
• Constitutively active human estrogen receptors containing amino acid substitutions for tyrosine 537 in the receptor protein.

  1996cited by this paper
• Measurement of the binding of tyrosyl phosphopeptides to SH2 domains: a reappraisal.

  1995cited by this paper
• HER-2 tyrosine kinase pathway targets estrogen receptor and promotes hormone-independent growth in human breast cancer cells.

  1995cited by this paper
• Phosphorylation of the human estrogen receptor on tyrosine 537 in vivo and by src family tyrosine kinases in vitro.

  1995cited by this paper
• Solution structure of the human pp60c-src SH2 domain complexed with a phosphorylated tyrosine pentapeptide.

  1995cited by this paper
• Protein modules and signalling networks

  1995cited by this paper
• Nongenomic actions of steroid hormones.

  1994cited by this paper
• Phosphatidylinositol 3-kinase p85 SH2 domain specificity defined by direct phosphopeptide/SH2 domain binding.

  1993cited by this paper
• Binding of a high affinity phosphotyrosyl peptide to the Src SH2 domain: crystal structures of the complexed and peptide-free forms.

  1993cited by this paper
• Crystal structure of the phosphotyrosine recognition domain SH2 of v-src complexed with tyrosine-phosphorylated peptides

  1993cited by this paper
• SH2 domains recognize specific phosphopeptide sequences.

  1993cited by this paper

• The pathogen-encoded signalling receptor Tir exploits host-like intrinsic disorder for infection

  2024cites this paper
• PELP1 and SRC kinase as important molecules in the estrogen-mediated pathway in human testis and epididymis.

  2023cites this paper
• Estradiol-Induced Epithelial to Mesenchymal Transition and Migration Are Inhibited by Blocking c-Src Kinase in Breast Cancer Cell Lines

  2023cites this paper
• Membrane-Initiated Estrogen, Androgen, and Progesterone Receptor Signaling in Health and Disease

  2021cites this paper
• Contribution of sex steroids and prolactin to the modulation of T and B cells during autoimmunity.

  2018cites this paper
• Steroid Hormone and Nuclear Receptor Signaling Pathways

  2018cites this paper
• Estradiol-induced regulation of GLUT 4 in 3 T 3L 1 cells : involvement of ESR 1 and AKT activation

  2017cites this paper
• High-confidence fusion gene detection in different tumor entities & biomarker discovery in breast cancer

  2017cites this paper
• Quantitative Affinity Determination by Fluorescence Anisotropy Measurements of Individual Nanoliter Droplets

  2017cites this paper
• Estradiol-induced regulation of GLUT4 in 3T3-L1 cells: involvement of ESR1 and AKT activation.

  2017cites this paper